End to Velosulin Human Insulin Shortage Announced by Novo Nordisk

Mar 1, 1995

Novo Nordisk has announced an end to the shortage of Velosulin Human insulin, which was in limited supply at the end of 1994.

The insulin is once again available through pharmacies and regular suppliers, with a few changes to the vial design.

A shorter and wider vial, similar to traditional insulin vial designs, will house the product in the same specifications as before the shortage.

If there are any questions or concerns about the availability of the product, the Novo Nordisk product information line can be reached at 1-800-727-6500.

Click Here To View Or Post Comments

Categories: Insulin, Novo Nordisk


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Mar 1, 1995

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.